Regulators of Proliferation and Apoptosis in Carcinoma of the Larynx

No abstract is available for this paper.

• Publication year

  1998

• Venue

  The Laryngoscope

• Publication date

  1998-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/00005537-199805000-00002PMID 9591537
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Short Communication Immunohistochemical Analysis of Mci-1 Protein in Human Tissues Differential Regulation of Mcl- 1 and Bcl-2 Protein Production Suggests a Unique Role for Mcl- 1 in Control of Programmed Cell Death In Vivo

  2007cited by this paper
• Head and Neck Surgery—Otolaryngology

  2000cited by this paper
• Mutation of p53 in Squamous Cell Cancer of the Head and Neck: Relationship to Tumor Cell Proliferation

  1997cited by this paper
• Prognostic Significance of BCL-2 Expression in Localized Squamous Cell Carcinoma of the Head and Neck

  1997cited by this paper
• Cyclin D1 expression in squamous cell carcinomas of the head and neck and in oral mucosa in relation to proliferation and apoptosis.

  1997cited by this paper
• Proliferation of epithelia of noninvolved mucosa in patients with head and neck cancer

  1996cited by this paper
• bcl-2 protein expression correlates with recurrence and survival in early stage head and neck cancer treated by radiotherapy.

  1996cited by this paper
• Assessment of apoptosis in relation to proliferation and mutational status of p53 gene in head and neck cancers.

  1996cited by this paper
• Bcl-2 expression correlates with favourable outcome in head and neck cancer treated by accelerated radiotherapy.

  1996cited by this paper
• BCL‐2 family proteins: Regulators of cell death involved in the pathogenesis of cancer and resistance to therapy

  1996cited by this paper
• Modulation of apoptosis-associated genes bcl-2, bcl-x, and bax during rat liver regeneration.

  1996cited by this paper
• Cyclin D1 gene amplification in human laryngeal squamous cell carcinomas: prognostic significance and clinical implications.

  1996cited by this paper
• Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies.

  1996cited by this paper
• Expression of the Bcl-2 homologue Mcl-1 correlates with survival of peripheral blood B lymphocytes.

  1996cited by this paper
• Immunohistochemical analysis of Bcl-2 family proteins in adenocarcinomas of the stomach.

  1996cited by this paper
• Cyclin D1/PRAD1 as a central target in oncogenesis.

  1996cited by this paper
• Cell kinetics of head and neck cancers.

  1995cited by this paper
• Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2.

  1994cited by this paper
• Immunohistochemical analysis of in vivo patterns of Bcl-X expression.

  1994cited by this paper
• Early glottic cancer.

  1994cited by this paper
• Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo.

  1994cited by this paper
• Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections.

  1991cited by this paper

• Interactive regulation of laryngeal cancer and neuroscience.

  2021cites this paper
• Biomarkers of laryngeal squamous cell carcinoma: a review.

  2021cites this paper
• Effect of the histone deacetylase inhibitor resminostat on head and neck squamous cell carcinoma cell lines

  2017cites this paper
• Cellular response to DNA interstrand crosslinks: the Fanconi anemia pathway

  2016cites this paper
• Convallaria keiskei as a novel therapeutic alternative for salivary gland cancer treatment by targeting myeloid cell leukemia‐1

  2016cites this paper
• Prognostic Value of Bcl-2 Expression in Squamous Cell Carcinoma of the Larynx: A Systematic Review

  2015influential citation
• Arsenic trioxide enhances the cytotoxic effect of cisplatin in head and neck squamous cell carcinoma cell lines.

  2012influential citation
• Radiosensitization of head and neck cancer cells by the phytochemical agent sulforaphane

  2011cites this paper
• Mcl-1 Expression Is Up-Regulated in Malignancies of the Parotid Gland

  2011cites this paper
• Bcl-2 targeted-therapy for the treatment of head and neck squamous cell carcinoma.

  2011cites this paper
• Apoptosis in the Development and Treatment of Laryngeal Cancer: Role of p53, Bcl-2 and Clusterin

  2009cites this paper
• Apoptosis in Carcinogenesis and Chemotherapy

  2009cites this paper
• Human oral cancers have altered expression of Bcl‐2 family members and increased expression of the anti‐apoptotic splice variant of Mcl‐1

  2009cites this paper
• PERK and PKR: Old kinases learn new tricks

  2008cites this paper
• Chemotherapy for laryngeal cancer--an apoptotic approach.

  2008cites this paper
• Prognostic factors and predictive tests in the treatment of head and neck squamous cell carcinoma

  2007cites this paper
• Expression of the Antiapoptotic Proteins Clusterin and Bcl-2 in Laryngeal Squamous Cell Carcinomas

  2006cites this paper
• Changes in Mcl-1 expression in rectal cancer in relation to neo-adjuvant radiotherapy

  2005cites this paper
• Cyclin D1 Protein Tissue Detection in Laryngeal Cancer

  2005cites this paper
• Genotyping of Patients with Sporadic and Radiation-Associated Meningiomas

  2005cites this paper
• RADIATION THERAPY OF HEAD AND NECK CANCER WITH SPECIAL EMPHASIS ON LOCOREGIONAL RECURRENCE AND ADVERSE EVENTS

  2004cites this paper
• Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.

  2004cites this paper
• Bcl-Xl protein expression in laryngeal squamous cell carcinoma.

  2004cites this paper
• C-Myc And Bcl-2 Expression In Supraglottic Squamous Cell Carcinoma of the Larynx

  2004cites this paper
• The Nuclear Localization of NFκB and p53 Is Positively Correlated with HPV16 E7 Level in Laryngeal Squamous Cell Carcinoma1

  2003cites this paper
• Cyclin A and Ki-67 expression as predictors for locoregional recurrence and outcome in laryngeal cancer patients treated with surgery and postoperative radiotherapy.

  2003cites this paper
• The nuclear localization of NFkappaB and p53 is positively correlated with HPV16 E7 level in laryngeal squamous cell carcinoma.

  2003cites this paper
• Prognostic value of p53 mutations, bax, and spontaneous apoptosis in maxillary sinus squamous cell carcinoma

  2002cites this paper
• THE EXPRESSION OF Bcl-2 AND PRO-CASPASE 3 IN HEAD AND NECK SQUAMOUS CELL CARCINOMA

  2002cites this paper
• Expression of Bcl‐2 Family Proteins in Advanced Laryngeal Squamous Cell Carcinoma: Correlation With Response to Chemotherapy and Organ Preservation

  2002influential citation
• Predictive Value of P53, BCL-2, and BAX in Advanced Head and Neck Carcinoma

  2002cites this paper
• Melatonin in Patients with Cancer of Extra-Reproductive Location

  2001cites this paper
• Prognostic value of the expression of p53 and bcl-2 in patients with laryngeal carcinoma

  2001cites this paper
• Prognostic significance of p53, bax and bcl-2 gene expression in patients with laryngeal carcinoma.

  2001cites this paper
• Squamous carcinoma of the head and neck: molecular mechanisms and potential biomarkers.

  2000cites this paper
• Molekularbiologische und immunhistochemische Prognosemarker bei Kopf-Hals-Plattenepithelkarzinomen

  2000cites this paper
• [Molecular biology and immunohistochemical prognostic markers in head and neck squamous epithelial carcinomas].

  2000cites this paper
• Life and death in otolaryngology: mechanisms of apoptosis and its role in the pathology and treatment of disease.

  1999cites this paper
• Recent advances in the molecular biology of head and neck tumours

  1999cites this paper
• Molecular markers as prognostic factors for local recurrence and radioresistance in head and neck squamous cell carcinoma.

  1999cites this paper
• Mithramycin a Induces Apoptosis and Potentiates Anti-tumor Activity of Cisplatin in Head and Neck Cancer Cell Line

  year unknowncites this paper